Pancreatic Cancer Research

ResearcherLanzhou University Second HospitalActive in the last 2 years

Wence Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2573-9170; OpenAlex author ID A5101914100. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 4 papers · 2024: 1 paper · 2025: 2 papers

Papers 10

  1. MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to promote the malignant progression of pan… Last author DOI 10.1186/s13046-025-03321-x↗
  2. Pancreatic cancer subtyping - the keystone of precision treatment. Last author DOI 10.3389/fimmu.2025.1563725↗
  3. Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells. Last author DOI 10.36721/pjps.2024.37.2.reg.327-336.1↗
  4. Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cance… Co-author DOI 10.3389/fimmu.2023.1170223↗
  5. A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer. Last author DOI 10.3389/fmolb.2023.1298077↗
  6. Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy. Last author DOI 10.3389/fonc.2023.1185093↗
  7. The Global, Regional and National Burden of Pancreatic Cancer Attributable to Smoking, 1990 to 2019: A Systematic Analysis from the Global Burden of Disease St… Last author DOI 10.3390/ijerph20021552↗
  8. miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis. Last author DOI 10.1111/jcmm.16405↗
  9. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. Co-author DOI 10.1002/jcp.26816↗
  10. Overexpression of p16ink4a regulates the Wnt/β‑catenin signaling pathway in pancreatic cancer cells. Last author DOI 10.3892/mmr.2017.8139↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huaqing Shi · 2 shared papers, 2024–2025 · strength 0.54
  2. Yan Du · 2 shared papers, 2023–2024 · strength 0.48
  3. Shi Dong · 2 shared papers, 2023–2024 · strength 0.43
  4. Xin Li · 2 shared papers, 2023 · strength 0.42
  5. Wenkai Jiang · 2 shared papers, 2023 · strength 0.42
  6. Zhengfeng Wang · 2 shared papers, 2021–2023 · strength 0.40
  7. Chunlu Dong · 2 shared papers, 2021–2024 · strength 0.38
  8. Zeyang Fan · 1 shared paper, 2025 · strength 0.33
  9. Yan Zhang · 1 shared paper, 2025 · strength 0.33
  10. Hao Xu · 2 shared papers, 2021–2023 · strength 0.32
  11. Shi Dong · 1 shared paper, 2025 · strength 0.30
  12. Chen Zhou · 1 shared paper, 2025 · strength 0.30
  13. Xin Li · 1 shared paper, 2025 · strength 0.30
  14. Ru He · 1 shared paper, 2023 · strength 0.26
  15. Fangfang Han · 1 shared paper, 2024 · strength 0.24
  16. Hui Zhang · 2 shared papers, 2018–2021 · strength 0.23
  17. Hui Zhang · 1 shared paper, 2023 · strength 0.18
  18. Hui Tang · 1 shared paper, 2023 · strength 0.18
  19. Haofei Chen · 1 shared paper, 2023 · strength 0.18
  20. Daoming Liang · 1 shared paper, 2023 · strength 0.18
  21. Weixiong Zhu · 1 shared paper, 2023 · strength 0.18
  22. Wenbo Meng · 2 shared papers, 2018 · strength 0.17
  23. Xin Li · 1 shared paper, 2021 · strength 0.14
  24. Lei Zhang · 1 shared paper, 2018 · strength 0.09
  25. Shaozhen Rui · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.